COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness
Authors
Keywords
-
Journal
Lancet Global Health
Volume 10, Issue 4, Pages e570-e573
Publisher
Elsevier BV
Online
2022-03-16
DOI
10.1016/s2214-109x(22)00075-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine
- (2021) Laurence Chu et al. VACCINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- From Vaccine Nationalism to Vaccine Equity — Finding a Path Forward
- (2021) Ingrid T. Katz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
- (2021) Alberto M Borobia et al. LANCET
- Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
- (2021) Amy Flaxman et al. LANCET
- Effectiveness of COVID‐19 vaccines: findings from real world studies
- (2021) David A Henry et al. MEDICAL JOURNAL OF AUSTRALIA
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
- (2021) Ugur Sahin et al. NATURE
- Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality
- (2021) Benjamin J. Cowling et al. NATURE MEDICINE
- Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
- (2021) Jose Mateus et al. SCIENCE
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis
- (2020) Jenny L. Schnyder et al. Travel Medicine and Infectious Disease
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
- (2020) Jordan R. Barrett et al. NATURE MEDICINE
- Intradermal travel vaccinations-when less means more
- (2019) Frieder Schaumburg et al. Travel Medicine and Infectious Disease
- Introducing new vaccines in low- and middle-income countries: challenges and approaches
- (2019) Adrienne Guignard et al. Expert Review of Vaccines
- Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Preliminary Report
- (2018) Steve Ahuka-Mundeke et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now